100 related articles for article (PubMed ID: 25017119)
1. Naringenin inhibits migration of bladder cancer cells through downregulation of AKT and MMP‑2.
Liao AC; Kuo CC; Huang YC; Yeh CW; Hseu YC; Liu JY; Hsu LS
Mol Med Rep; 2014 Sep; 10(3):1531-6. PubMed ID: 25017119
[TBL] [Abstract][Full Text] [Related]
2. Naringenin inhibited migration and invasion of glioblastoma cells through multiple mechanisms.
Chen YY; Chang YM; Wang KY; Chen PN; Hseu YC; Chen KM; Yeh KT; Chen CJ; Hsu LS
Environ Toxicol; 2019 Mar; 34(3):233-239. PubMed ID: 30431227
[TBL] [Abstract][Full Text] [Related]
3. [Study on effect of naringenin in inhibiting migration and invasion of breast cancer cells and its molecular mechanism].
Sun Y; Gu J
Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(6):1144-50. PubMed ID: 26226761
[TBL] [Abstract][Full Text] [Related]
4. Naringin inhibits matrix metalloproteinase-9 expression and AKT phosphorylation in tumor necrosis factor-alpha-induced vascular smooth muscle cells.
Lee EJ; Kim DI; Kim WJ; Moon SK
Mol Nutr Food Res; 2009 Dec; 53(12):1582-91. PubMed ID: 19810018
[TBL] [Abstract][Full Text] [Related]
5. Berberine, an isoquinoline alkaloid, inhibits the metastatic potential of breast cancer cells via Akt pathway modulation.
Kuo HP; Chuang TC; Tsai SC; Tseng HH; Hsu SC; Chen YC; Kuo CL; Kuo YH; Liu JY; Kao MC
J Agric Food Chem; 2012 Sep; 60(38):9649-58. PubMed ID: 22950834
[TBL] [Abstract][Full Text] [Related]
6. [Inhibitory effect of 2'-hydroxyflavanone on proliferation, invasion and migration of bladder cancer cells in vitro via blocking AKT/STAT3 signaling pathway].
Zhu J; Wu K; Chen Y; Ning Z; Zhang K; DU Y; Ding C; Wang X; Fan J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Mar; 30(3):237-40. PubMed ID: 24606737
[TBL] [Abstract][Full Text] [Related]
7. Naringenin attenuates the release of pro-inflammatory mediators from lipopolysaccharide-stimulated BV2 microglia by inactivating nuclear factor-κB and inhibiting mitogen-activated protein kinases.
Park HY; Kim GY; Choi YH
Int J Mol Med; 2012 Jul; 30(1):204-10. PubMed ID: 22552813
[TBL] [Abstract][Full Text] [Related]
8. Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-κB and matrix metalloproteinase-2/-9 signaling pathways.
Lai WW; Hsu SC; Chueh FS; Chen YY; Yang JS; Lin JP; Lien JC; Tsai CH; Chung JG
Anticancer Res; 2013 May; 33(5):1941-50. PubMed ID: 23645742
[TBL] [Abstract][Full Text] [Related]
9. Gypenosides inhibits migration and invasion of human oral cancer SAS cells through the inhibition of matrix metalloproteinase-2 -9 and urokinase-plasminogen by ERK1/2 and NF-kappa B signaling pathways.
Lu KW; Chen JC; Lai TY; Yang JS; Weng SW; Ma YS; Lu PJ; Weng JR; Chueh FS; Wood WG; Chung JG
Hum Exp Toxicol; 2011 May; 30(5):406-15. PubMed ID: 20511288
[TBL] [Abstract][Full Text] [Related]
10. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
[TBL] [Abstract][Full Text] [Related]
11. Ang II-AT1R increases cell migration through PI3K/AKT and NF-κB pathways in breast cancer.
Zhao Y; Wang H; Li X; Cao M; Lu H; Meng Q; Pang H; Li H; Nadolny C; Dong X; Cai L
J Cell Physiol; 2014 Nov; 229(11):1855-62. PubMed ID: 24692224
[TBL] [Abstract][Full Text] [Related]
12. Gallic acid inhibits migration and invasion in human osteosarcoma U-2 OS cells through suppressing the matrix metalloproteinase-2/-9, protein kinase B (PKB) and PKC signaling pathways.
Liao CL; Lai KC; Huang AC; Yang JS; Lin JJ; Wu SH; Gibson Wood W; Lin JG; Chung JG
Food Chem Toxicol; 2012 May; 50(5):1734-40. PubMed ID: 22387266
[TBL] [Abstract][Full Text] [Related]
13. Naringenin inhibits proliferation, migration, and invasion as well as induces apoptosis of gastric cancer SGC7901 cell line by downregulation of AKT pathway.
Bao L; Liu F; Guo HB; Li Y; Tan BB; Zhang WX; Peng YH
Tumour Biol; 2016 Aug; 37(8):11365-74. PubMed ID: 26960693
[TBL] [Abstract][Full Text] [Related]
14. Acacetin (5,7-dihydroxy-4'-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-κB/Akt signaling in prostate cancer cells.
Kim HR; Park CG; Jung JY
Int J Mol Med; 2014 Feb; 33(2):317-24. PubMed ID: 24285354
[TBL] [Abstract][Full Text] [Related]
15. Surfactin suppresses TPA-induced breast cancer cell invasion through the inhibition of MMP-9 expression.
Park SY; Kim JH; Lee YJ; Lee SJ; Kim Y
Int J Oncol; 2013 Jan; 42(1):287-96. PubMed ID: 23151889
[TBL] [Abstract][Full Text] [Related]
16. Co-treatment of THP-1 cells with naringenin and curcumin induces cell cycle arrest and apoptosis via numerous pathways.
Shi D; Xu Y; Du X; Chen X; Zhang X; Lou J; Li M; Zhuo J
Mol Med Rep; 2015 Dec; 12(6):8223-8. PubMed ID: 26496980
[TBL] [Abstract][Full Text] [Related]
17. Gallic acid suppresses the migration and invasion of PC-3 human prostate cancer cells via inhibition of matrix metalloproteinase-2 and -9 signaling pathways.
Liu KC; Huang AC; Wu PP; Lin HY; Chueh FS; Yang JS; Lu CC; Chiang JH; Meng M; Chung JG
Oncol Rep; 2011 Jul; 26(1):177-84. PubMed ID: 21503582
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of fatty acid synthase suppresses osteosarcoma cell invasion and migration via downregulation of the PI3K/Akt signaling pathway in vitro.
Liu ZL; Mao JH; Peng AF; Yin QS; Zhou Y; Long XH; Huang SH
Mol Med Rep; 2013 Feb; 7(2):608-12. PubMed ID: 23229760
[TBL] [Abstract][Full Text] [Related]
19. Phyllanthus urinaria suppresses human osteosarcoma cell invasion and migration by transcriptionally inhibiting u-PA via ERK and Akt signaling pathways.
Lu KH; Yang HW; Su CW; Lue KH; Yang SF; Hsieh YS
Food Chem Toxicol; 2013 Feb; 52():193-9. PubMed ID: 23201449
[TBL] [Abstract][Full Text] [Related]
20. Gleditsioside B, a triterpene saponin isolated from the anomalous fruits of Gleditsia sinensis Lam., abrogates bFGF-induced endothelial cell migration through preventing the activation of MMP-2 and FAK via inhibiting ERK and PI3K/AKT signaling pathways.
Tong B; Lu D; Wei Z; Wang T; Xia Y; Dai Y
Vascul Pharmacol; 2013 Jan; 58(1-2):118-26. PubMed ID: 23026290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
